::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

GASTROINTESTINAL SIGNS DID NOT ARISE AND HAD POSITIVE STOOL CHECKS THE SERIOUSNESS OF THE LUNG INFECTION IS NIL WITH COVID POSITIVE PATIENT

AUTHORS:

Dr Arooj Zulfiqar, Dr Abdul Wahab, Qazi Salman

ABSTRACT:

The growth and dissemination of 2019 novel Covid infected pneumonia (COVID‐19) from Wuhan, China, it has spread globally. We deleted the details on 14 patients with laboratory‐confirmed COVID‐19 from Jinhua City Central clinic through 22 February 2020. We observed that the nuclear corrosive detection of COVID‐19 was equally effective in fecal cases, tested for pharyngeal swab cases. Our current research was conducted at Jinnah Hospital, Lahore from March 2020 to August 2020. We observed that the nucleic COVID‐19 corrosive identification in fecal examples was equally reliable when tested using pharyngeal swab examples. We have noted that there were no gastrointestinal side-effects and little to do with risk of lung infection in patients with a positive stool exam. The effects will help to explain the clinical developments and the evolution of COVID‐19 therapeutic limits. We also observed that gastrointestinal side-effects did not exist and had almost no connection to the extent of the lung infection in patients with a positive stool exam. These findings will assist in interpreting the therapeutic commitment and therapeutic boundary progressions of COVID‐19. Keywords: Gastrointestinal Signs, Covid-19 patient, Positive.